Bristol Myers Squibb (CELG-RI) Change in Taxes (2009 - 2026)

Bristol Myers Squibb has disclosed Change in Taxes across 18 years of filings, most recently posting $187.0 million for Q1 2026.

• In Q1 2026, Change in Taxes rose 246.3% year-over-year to $187.0 million; the TTM figure through Mar 2026 stood at $129.0 million (up 106.1% YoY), while the FY2025 annual figure was -$4.0 million, up 99.68% from the prior year.
• Change in Taxes advanced to $187.0 million in Q1 2026, from -$324.0 million in the prior quarter.
• Over the last five years, Change in Taxes for CELG-RI reached as high as $1.0 billion in Q4 2023 and fell as low as -$2.1 billion in Q2 2023.
• The 5-year median for Change in Taxes is $54.0 million (2025), against an average of -$182.5 million.
• Annual changes were most pronounced in 2023 — Change in Taxes sank 786.67% — and 2025, when it surged 354.89%.
• A 5-year view of Change in Taxes shows it stood at -$1.1 billion in 2022, then soared by 193.8% to $1.0 billion in 2023, then tumbled by 88.41% to $121.0 million in 2024, then sank by 367.77% to -$324.0 million in 2025, then soared by 157.72% to $187.0 million in 2026.
• According to Business Quant data, Change in Taxes over the past three periods registered $187.0 million, -$324.0 million, and $887.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.